Active telephone surveillance to evaluate adverse events among civilian smallpox vaccine recipients

Arnulfo A. Muralles, Paula Ray, Steven Black, Henry Shinefield, Christine G. Casey, Scott Campbell, Robert T. Chen, Colin Marchant, Jerome Klein, Elizabeth Barnett, Phillip LaRussa, Anne Gershon, Neal Halsey, Robert Davis, Cornelia L. Dekker, Margaret Rennels, Kathryn Edwards

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: Better characterize and monitor adverse events following Dryvax ® vaccinia vaccination in civilian health care workers and other first responders. Design: Telephone interviews to ascertain adverse events experienced. Results: Eight hundred twenty-five vaccinees, including 44 in the comparison group, were interviewed. At 10 days, 71.4% reported blisters, 35.1% reported bumps at the vaccination site, 48.5% swelling, 47.3% scab, tiredness/lethargy/fatigue (43.6%), headache (34.2%), lymph node swelling/tenderness (28.5%), muscle pain (23.1%), chills (14.4%), joint pain 11.8%, and fever >100°F (12.5%). The 12.5% reported missing work because of vaccine adverse events. Most adverse events were anticipated and of short duration.

Original languageEnglish (US)
Pages (from-to)476-484
Number of pages9
JournalVaccine
Volume24
Issue number4
DOIs
StatePublished - Jan 23 2006

Fingerprint

Smallpox Vaccine
Telephone
pain
Vaccination
vaccination
vaccines
blisters
Vaccinia
Chills
Lethargy
headache
Vaccinium
monitoring
Myalgia
Arthralgia
Blister
health care workers
fever
Fatigue
lymph nodes

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Muralles, A. A., Ray, P., Black, S., Shinefield, H., Casey, C. G., Campbell, S., ... Edwards, K. (2006). Active telephone surveillance to evaluate adverse events among civilian smallpox vaccine recipients. Vaccine, 24(4), 476-484. https://doi.org/10.1016/j.vaccine.2005.07.089

Active telephone surveillance to evaluate adverse events among civilian smallpox vaccine recipients. / Muralles, Arnulfo A.; Ray, Paula; Black, Steven; Shinefield, Henry; Casey, Christine G.; Campbell, Scott; Chen, Robert T.; Marchant, Colin; Klein, Jerome; Barnett, Elizabeth; LaRussa, Phillip; Gershon, Anne; Halsey, Neal; Davis, Robert; Dekker, Cornelia L.; Rennels, Margaret; Edwards, Kathryn.

In: Vaccine, Vol. 24, No. 4, 23.01.2006, p. 476-484.

Research output: Contribution to journalArticle

Muralles, AA, Ray, P, Black, S, Shinefield, H, Casey, CG, Campbell, S, Chen, RT, Marchant, C, Klein, J, Barnett, E, LaRussa, P, Gershon, A, Halsey, N, Davis, R, Dekker, CL, Rennels, M & Edwards, K 2006, 'Active telephone surveillance to evaluate adverse events among civilian smallpox vaccine recipients', Vaccine, vol. 24, no. 4, pp. 476-484. https://doi.org/10.1016/j.vaccine.2005.07.089
Muralles AA, Ray P, Black S, Shinefield H, Casey CG, Campbell S et al. Active telephone surveillance to evaluate adverse events among civilian smallpox vaccine recipients. Vaccine. 2006 Jan 23;24(4):476-484. https://doi.org/10.1016/j.vaccine.2005.07.089
Muralles, Arnulfo A. ; Ray, Paula ; Black, Steven ; Shinefield, Henry ; Casey, Christine G. ; Campbell, Scott ; Chen, Robert T. ; Marchant, Colin ; Klein, Jerome ; Barnett, Elizabeth ; LaRussa, Phillip ; Gershon, Anne ; Halsey, Neal ; Davis, Robert ; Dekker, Cornelia L. ; Rennels, Margaret ; Edwards, Kathryn. / Active telephone surveillance to evaluate adverse events among civilian smallpox vaccine recipients. In: Vaccine. 2006 ; Vol. 24, No. 4. pp. 476-484.
@article{51278aa64f224a00b7b038a3482429ab,
title = "Active telephone surveillance to evaluate adverse events among civilian smallpox vaccine recipients",
abstract = "Objective: Better characterize and monitor adverse events following Dryvax {\circledR} vaccinia vaccination in civilian health care workers and other first responders. Design: Telephone interviews to ascertain adverse events experienced. Results: Eight hundred twenty-five vaccinees, including 44 in the comparison group, were interviewed. At 10 days, 71.4{\%} reported blisters, 35.1{\%} reported bumps at the vaccination site, 48.5{\%} swelling, 47.3{\%} scab, tiredness/lethargy/fatigue (43.6{\%}), headache (34.2{\%}), lymph node swelling/tenderness (28.5{\%}), muscle pain (23.1{\%}), chills (14.4{\%}), joint pain 11.8{\%}, and fever >100°F (12.5{\%}). The 12.5{\%} reported missing work because of vaccine adverse events. Most adverse events were anticipated and of short duration.",
author = "Muralles, {Arnulfo A.} and Paula Ray and Steven Black and Henry Shinefield and Casey, {Christine G.} and Scott Campbell and Chen, {Robert T.} and Colin Marchant and Jerome Klein and Elizabeth Barnett and Phillip LaRussa and Anne Gershon and Neal Halsey and Robert Davis and Dekker, {Cornelia L.} and Margaret Rennels and Kathryn Edwards",
year = "2006",
month = "1",
day = "23",
doi = "10.1016/j.vaccine.2005.07.089",
language = "English (US)",
volume = "24",
pages = "476--484",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Active telephone surveillance to evaluate adverse events among civilian smallpox vaccine recipients

AU - Muralles, Arnulfo A.

AU - Ray, Paula

AU - Black, Steven

AU - Shinefield, Henry

AU - Casey, Christine G.

AU - Campbell, Scott

AU - Chen, Robert T.

AU - Marchant, Colin

AU - Klein, Jerome

AU - Barnett, Elizabeth

AU - LaRussa, Phillip

AU - Gershon, Anne

AU - Halsey, Neal

AU - Davis, Robert

AU - Dekker, Cornelia L.

AU - Rennels, Margaret

AU - Edwards, Kathryn

PY - 2006/1/23

Y1 - 2006/1/23

N2 - Objective: Better characterize and monitor adverse events following Dryvax ® vaccinia vaccination in civilian health care workers and other first responders. Design: Telephone interviews to ascertain adverse events experienced. Results: Eight hundred twenty-five vaccinees, including 44 in the comparison group, were interviewed. At 10 days, 71.4% reported blisters, 35.1% reported bumps at the vaccination site, 48.5% swelling, 47.3% scab, tiredness/lethargy/fatigue (43.6%), headache (34.2%), lymph node swelling/tenderness (28.5%), muscle pain (23.1%), chills (14.4%), joint pain 11.8%, and fever >100°F (12.5%). The 12.5% reported missing work because of vaccine adverse events. Most adverse events were anticipated and of short duration.

AB - Objective: Better characterize and monitor adverse events following Dryvax ® vaccinia vaccination in civilian health care workers and other first responders. Design: Telephone interviews to ascertain adverse events experienced. Results: Eight hundred twenty-five vaccinees, including 44 in the comparison group, were interviewed. At 10 days, 71.4% reported blisters, 35.1% reported bumps at the vaccination site, 48.5% swelling, 47.3% scab, tiredness/lethargy/fatigue (43.6%), headache (34.2%), lymph node swelling/tenderness (28.5%), muscle pain (23.1%), chills (14.4%), joint pain 11.8%, and fever >100°F (12.5%). The 12.5% reported missing work because of vaccine adverse events. Most adverse events were anticipated and of short duration.

UR - http://www.scopus.com/inward/record.url?scp=29244459412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29244459412&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2005.07.089

DO - 10.1016/j.vaccine.2005.07.089

M3 - Article

C2 - 16216396

AN - SCOPUS:29244459412

VL - 24

SP - 476

EP - 484

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 4

ER -